STAT+: Failure of Novartis Lp(a) drug raises questions about cardiovascular strategy
· statnews.com · popularity 34/100 · 0 similar stories today · Chronic Conditions (Health & Life Sciences)
Read the original at statnews.com →
Summary
Medical mystery at the AHA conference: A Novartis drug lowered a risk marker for cardiovascular disease but did not lower chance of heart attack or stroke.
Found in: STAT News. Rating basis: single outlet; outlet tier 4; 1 feeds; feed position 1.